Funding
This research was funded by the Horizon 2020 SME Instrument Phase 2 Project: HPV OncoPredict (Grant agreement ID: 806551). MA and AL were supported by the Horizon 2020 Framework Programme for Research and Innovation of the European Commission, through the RISCC Network (Grant No. 847845).